首页> 美国卫生研究院文献>iScience >Lotus-root-shaped cell-encapsulated construct as a retrieval graft for long-term transplantation of human iPSC-derived β-cells
【2h】

Lotus-root-shaped cell-encapsulated construct as a retrieval graft for long-term transplantation of human iPSC-derived β-cells

机译:莲藕形细胞包封的构建体作为人IPSC衍生β细胞长期移植的检索移植物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Cell therapy using human-stem-cell-derived pancreatic beta cells (hSC-βs) is a potential treatment method for type 1 diabetes mellitus (T1D). For therapeutic safety, hSC-βs need encapsulation in grafts that are scalable and retrievable. In this study, we developed a lotus-root-shaped cell-encapsulated construct (LENCON) as a graft that can be retrieved after long-term hSC-β transplantation. This graft had six multicores encapsulating hSC-βs located within 1 mm from the edge. It controlled the recipient blood glucose levels for a long-term, following transplantation in immunodeficient diabetic mice. LENCON xenotransplanted into immunocompetent mice exhibited retrievability and maintained the functionality of hSC-βs for over 1 year after transplantation. We believe that LENCON can contribute to the treatment of T1D through long-term transplantation of hSC-βs and in many other forms of cell therapy.
机译:使用人干细胞衍生的胰腺β细胞(HSC-βS)的细胞疗法是1型糖尿病(T1D)的潜在处理方法。对于治疗安全,HSC-βS需要在可伸缩和可检索的移植物中封装。在该研究中,我们开发了一种莲藕形的细胞包封构建体(LENCON)作为可在长期HSC-β移植后检索的移植物。该移植物具有六种多设备封装在距边缘1毫秒内的HSC-β。它在免疫缺陷糖尿病小鼠中移植后控制受体血糖水平长期。 Lencon Xenotroansplanted进入免疫活性小鼠表现出可检索性并在移植后1年内保持HSC-βS的功能。我们认为LENCON可以通过HSC-βS的长期移植和许多其他形式的细胞疗法治疗T1D的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号